Reproductive technology company Memphasys came out of a trading halt on Monday morning, telling investors that it has received binding commitments to raise $1.275 million through a strategic placement. In a statement to the ASX, Memphasys said the commitments were from new and existing shareholders, amounting to 212,500,000 ordinary shares at $0.006 per share. Participants... The post Memphasys secures binding commitments for $1.275 million through share placement appeared first on Australian Manufacturing Forum.
